AzTrials
AzTrials

OlfactionDEXDERNCT02653378

The Effects of Acute Caloric Deprivation on Odour Identification and Food Reward

A study testing DIET and EX in people with Olfaction and Diet, run by University of Ottawa.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine how the modality of energy depletion can differently impact appetite hormones, ad libitum food intake, food hedonics, and olfaction. Read more about this study

Who is it for?
Any age, men onlyHealthy volunteers can take part
Conditions the study is for
Olfaction, Diet, Exercise
What is being tested?
DIET and EX
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
No sites listed yet
Study dates
Nov 2009to Mar 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Men only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Free from any illness that could influence outcome of the experiment
  • Weight-stable for >6months
  • aged between 18-40 years

Who cannot join

  • diabetic
  • smoker
  • medication

About this study

The purpose of this study is to determine how the modality of energy depletion can differently impact appetite hormones, ad libitum food intake, food hedonics, and olfaction.

Read the detailed description

The objectives of the current randomized controlled study were to examine how the modality of an acute 3 day isocaloric -25% energy depletion by dieting alone or by aerobic exercise alone differently impacts appetite and appetite-related hormones, ad libitum energy intake (EI), food hedonics and food reward, and olfaction. It was hypothesized that independent of modality of depletion, that relative to the control, there would be increased ad libitum feeding and food reward, improvements in smell performance, and a decline in fasting leptin and increase in fasting total ghrelin. It was also hypothesized that the increased food reward would prove to be a predictor of ad libitum EI and that relative to the depletion by aerobic exercise alone, the depletion by diet alone would produce greater compensatory increases in appetite, ad libitum EI, and food reward.

Statistics

To test for differences in body weight, plasma hormone concentrations, relative-reinforcing value of food (RRVF), and olfaction across each condition of the study, repeated measures ANOVA controlling for day 1 as a covariate was employed. Pairwise comparisons at day 4 using Sidak adjustment to account for multiple comparisons are reported when the ANOVA was significant. One way repeated measures ANOVAs with Sidak adjustments for multiple comparisons were used to test for differences in variables measured only at day 4: body composition (fat mas, %Fat, and fat free mass), appetite, palatability, and ad libitum EI.

Being tested
DIET, EX
Medical subject headings
Anosmia, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DIETBehavioural

    25% Energy Depletion by Diet only for 3 Days

  • EXBehavioural

    25% Energy Depletion by Exercise only for 3 Days

Study groups in NCT02653378
Study groupRoleWhat they receive
DIET ARMActive comparatorA 25% energy depletion (daily for 3 days) induced by reducing the amount of energy intake that would otherwise keep the individual in energy balance.
Receives: Behavioral: DIET
EX ARMActive comparatorA 25% energy depletion (daily for 3 days) induced by performing aerobic exercise at 50% of V02max.
Receives: Behavioral: EX

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Ad Libitum Energy Intake at Buffet Lunch--total kcals consumed at lunch meal measured to nearest 0.5grams.

    Ad libitum measure of energy intake at lunch time at Day 1 and Day 4 of study

    Measured: Day 1 and Day 4 of each study arm (DIET and EX)

Secondary outcomes (4)
  1. Change in fasting measure of Leptin

    One fasting sample of plasma Leptin

    Measured: Day 1 and Day 4 of each study arm (DIET and EX)

  2. Change in fasting measure of Ghrelin

    One fasting sample of plasma Ghrelin taken at Day 1 and Day 4 of study

    Measured: Day 1 and Day 4 of each study arm (DIET and EX)

  3. Change in Relative-Reinforcing Value of Food as measured by food points earned during a computerized behavioral choice tast

    Computer task measuring reinforcing value of preferred snack food and preferred fruit at Day 1 and Day 4 of study

    Measured: Day 1 and Day 4 of each study arm (DIET and EX)

  4. Olfaction--Odor Detection Threshold measured by Sniffin Sticks odorized pens

    Measure of odour threshold for n-butanol taken at Day 1 and Day 4 of study

    Measured: Day 1 and Day 4 of each study arm (DIET and EX)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2016 (estimated)
  2. Study startNov 2009
  3. Primary completionMar 2012
  4. Study completionMar 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02653378
Sponsor's protocol ID
H09-09-03
Acronym
DEXDER
Status last verified
Jan 2016
First submitted
6 Jan 2016
Last updated
12 Jan 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • McNeil J, Lamothe G, Cameron JD, Riou ME, Cadieux S, Lafreniere J, Goldfield G, Willbond S, Prud'homme D, Doucet E. Investigating predictors of eating: is resting metabolic rate really the strongest proxy of energy intake? Am J Clin Nutr. 2017 Nov;106(5):1206-1212. doi: 10.3945/ajcn.117.153718. Epub 2017 Sep 6.

    PubMed 28877891
  • Cameron JD, Goldfield GS, Riou ME, Finlayson GS, Blundell JE, Doucet E. Energy depletion by diet or aerobic exercise alone: impact of energy deficit modality on appetite parameters. Am J Clin Nutr. 2016 Apr;103(4):1008-16. doi: 10.3945/ajcn.115.115584. Epub 2016 Feb 17.

    PubMed 26888712

Questions about this trial

What is this clinical trial studying?

A study testing DIET and EX in people with Olfaction and Diet, run by University of Ottawa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Ad Libitum Energy Intake at Buffet Lunch--total kcals consumed at lunch meal measured to nearest 0.5grams. (time frame: Day 1 and Day 4 of each study arm (DIET and EX)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02653378, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in